Banque Cantonale Vaudoise Raises Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

0


Banque Cantonale Vaudoise grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 49.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 14,627 shares of the company’s stock after acquiring an additional 4,817 shares during the quarter. Banque Cantonale Vaudoise’s holdings in GE HealthCare Technologies were worth $1,331,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Fortitude Family Office LLC purchased a new position in shares of GE HealthCare Technologies in the 4th quarter worth $29,000. Turtle Creek Wealth Advisors LLC bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $30,000. Sachetta LLC bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $31,000. Rise Advisors LLC raised its position in GE HealthCare Technologies by 241.4% during the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after purchasing an additional 239 shares during the period. Finally, Valued Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $33,000. Institutional investors own 82.06% of the company’s stock.

Insiders Place Their Bets

In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,315 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, May 1st. The stock was acquired at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the acquisition, the insider now owns 75,796 shares in the company, valued at approximately $5,799,909.92. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. In related news, CEO Jan Makela sold 20,227 shares of the firm’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $81.57, for a total transaction of $1,649,916.39. Following the sale, the chief executive officer now owns 63,348 shares of the company’s stock, valued at $5,167,296.36. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Frank R. Jimenez bought 1,315 shares of the business’s stock in a transaction on Wednesday, May 1st. The stock was bought at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the purchase, the insider now directly owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The disclosure for this purchase can be found here. Insiders have sold a total of 90,482 shares of company stock worth $7,369,137 in the last three months. Corporate insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on GEHC. Argus increased their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Mizuho lowered their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a report on Wednesday, May 1st. Citigroup upped their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. The Goldman Sachs Group started coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price objective for the company. Finally, Evercore ISI increased their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus target price of $94.09.

Read Our Latest Analysis on GEHC

GE HealthCare Technologies Stock Down 0.3 %

Shares of NASDAQ GEHC opened at $79.17 on Friday. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The firm has a market capitalization of $36.14 billion, a price-to-earnings ratio of 23.15, a PEG ratio of 2.86 and a beta of 1.22. The stock has a 50 day moving average price of $80.68 and a 200 day moving average price of $81.32. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.83 and a current ratio of 1.06.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.90. The business had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The business’s revenue was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.85 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Featured Stories

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)



Receive News & Ratings for GE HealthCare Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for GE HealthCare Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.

link

Leave a Reply

Your email address will not be published. Required fields are marked *